Articles

Low-dose Btk inhibitors selectively block platelet activation by CLEC-2

Institute of Cardiovascular Sciences, University of Birmingham
Institute for Cardiovascular and Metabolic Research, University of Reading,
Institute of Cardiovascular Sciences, University of Birmingham,
Institute of Cardiovascular Sciences, University of Birmingham,
Institute of Cardiovascular Sciences, University of Birmingham,
Institute of Cardiovascular Sciences, University of Birmingham,
Institute of Cardiovascular Sciences, University of Birmingham,
Universities of Birmingham and Nottingham, Midlands;
Institute of Cardiovascular Sciences, University of Birmingham,
Universities of Birmingham and Nottingham, Midlands,
Universities of Birmingham and Nottingham, Midlands,
Institute of Cardiovascular Sciences, University of Birmingham,
Institute of Cardiovascular Sciences, University of Birmingham, UK;
Department of Immunology, Heartlands Hospital, Birmingham,
Department of Immunology, Heartlands Hospital, Birmingham
Institute for Cardiovascular and Metabolic Research, University of Reading, UK;
Institute for Physiological Chemistry & Pathobiochemistry, University of Münster, Germany;
Department of Haematology, Queen Elizabeth Hospital, Birmingham, UK
Universities of Birmingham and Nottingham, Midlands, UK;
Institute for Cardiovascular and Metabolic Research, University of Reading, UK;
Vol. 106 No. 1 (2021): January, 2021 https://doi.org/10.3324/haematol.2019.218545